Kalvista Pharmaceuticals, Inc. (KALV)

Last Three Months

02-Feb-24 -- 01-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

5

+1

0

+2

0

+3

Two Year Chart

02-May-22 -- 01-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
21-Feb-24 9:48 PM View:	20-Feb-24 Option Sale ($170.12K)	Yea Christopher Chief Development Officer		Kalvista Pharmaceuticals, Inc. - KALV	58% 46.05K to 72.89K	0	0	--	--	Show Txns Hide Txns

21-Feb-24 9:51 PM View:	20-Feb-24 Sale (Planned) ($133.45K)	Feener Edward P. Chief Scientific Officer		Kalvista Pharmaceuticals, Inc. - KALV	56% 39.83K to 62.16K	0	0	--	--	Show Txns Hide Txns

21-Feb-24 9:41 PM View:	20-Feb-24 Option Sale ($351.29K)	Crockett Thomas Andrew CEO Director		Kalvista Pharmaceuticals, Inc. - KALV	80% 117.53K to 211.2K	0	0	--	--	Show Txns Hide Txns

21-Feb-24 9:44 PM View:	20-Feb-24 Option Sale ($201.77K)	Audhya Paul K. Chief Medical Officer		Kalvista Pharmaceuticals, Inc. - KALV	45% 36.57K to 52.89K	0	0	--	--	Show Txns Hide Txns

08-Feb-24 8:11 PM View:	08-Feb-24 Purchase $437.28K	Venrock Healthcare Capital ... 10% Owner		Kalvista Pharmaceuticals, Inc. - KALV	2% 4.74M to 4.82M	0	0	--	--	Show Txns Hide Txns

21-Feb-24 9:46 PM View:	20-Feb-24 Option Sale ($321.85K)	Palleiko Ben CHIEF EXECUTIVE OFFICER Director		Kalvista Pharmaceuticals, Inc. - KALV	67% 112.44K to 187.31K	0	0	--	--	Show Txns Hide Txns